References of "MAGIS, Delphine"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailNeurostimulation for Headaches: Where Are We? Where Are We Going?
MAGIS, Delphine ULg

in May, Arne; Baron, Ralf (Eds.) Headache and Pain (2014)

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailNeuromodulation of chronic headaches: position statement from the European Headache Federation
Martelletti, P; Jensen, R; Antal, A et al

in Journal of Headache & Pain (2013), 14

The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic tension-type headache, chronic cluster headache, hemicrania continua) is challenging as serious side ... [more ▼]

The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic tension-type headache, chronic cluster headache, hemicrania continua) is challenging as serious side effects frequently complicate the course of medical treatment and some patients may be even medically intractable. When a definitive lack of responsiveness to conservative treatments is ascertained and medication overuse headache is excluded, neuromodulation options can be considered in selected cases.Here, the various invasive and non-invasive approaches, such as hypothalamic deep brain stimulation, occipital nerve stimulation, stimulation of sphenopalatine ganglion, cervical spinal cord stimulation, vagus nerve stimulation, transcranial direct current stimulation, repetitive transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation are extensively published although proper RCT-based evidence is limited. The European Headache Federation herewith provides a consensus statement on the clinical use of neuromodulation in headache, based on theoretical background, clinical data, and side effect of each method. This international consensus further gives recommendations for future studies on these new approaches.In spite of a growing field of stimulation devices in headaches treatment, further controlled studies to validate, strengthen and disseminate the use of neurostimulation are clearly warranted. Consequently, until these data are available any neurostimulation device should only be used in patients with medically intractable syndromes from tertiary headache centers either as part of a valid study or have shown to be effective in such controlled studies with an acceptable side effect profile. [less ▲]

Full Text
Peer Reviewed
See detailPearls and pitfalls: Electrophysiology for primary headaches
MAGIS, Delphine ULg; Vigano, Alessandro; SAVA, Simona Liliana ULg et al

in Cephalalgia : An International Journal of Headache (2013)

Detailed reference viewed: 37 (5 ULg)
See detailPerspectives thérapeutiques dans la migraine
MAGIS, Delphine ULg

Scientific conference (2013, March 22)

Detailed reference viewed: 23 (6 ULg)
Full Text
Peer Reviewed
See detailTranscranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine
Vigano, Alessandro; Sasso d'Elia, Tullia; SAVA, Simona Liliana ULg et al

in Journal of Headache & Pain (2013), 14(23),

Detailed reference viewed: 50 (4 ULg)
Full Text
Peer Reviewed
See detailLateral inhibition in visual cortex of migraine patients between attacks
Coppola, Gianluca; Parisi, Vincenzo; Di Lorenzo, Cherubino et al

in Journal of Headache & Pain (2013), 14

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailMigraine prevention with a supraorbital transcutaneous stimulator. A randomized controlled trial.
Schoenen, Jean ULg; Vandersmissen, Bart; Jeangette, Sandrine et al

in Neurology (2013), 80

Detailed reference viewed: 80 (3 ULg)
Full Text
Peer Reviewed
See detailScientific advances in headache research: an update on neurostimulation
Hoffmann, Jan; MAGIS, Delphine ULg

in Expert Review of Neurotherapeutics (2013), 13(1), 15-17

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailQuadripulse Repetitive Transcranial Magnetic Stimulation on Visual Cortex for Chronic Migraine Prevention: A Pilot-Trial
Sasso d'Elia, Tullia; Vigano, Alessandro; Fataki, Michel et al

in Cephalalgia : An International Journal of Headache (2013), 33(8), 49

Detailed reference viewed: 8 (0 ULg)
See detailNeurostimulation et céphalées
MAGIS, Delphine ULg

Scientific conference (2012, December 11)

Detailed reference viewed: 7 (3 ULg)
Peer Reviewed
See detailNeurostimulation for headaches
MAGIS, Delphine ULg

Conference (2012, October 07)

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detailAnodal transcranial direct current stimulation over the visual cortex as a preventive treatment of migraine: a proof-of-concept study.
Sasso d'Elia, Tullia; Vigano, Alessandro; SAVA, Simona Liliana ULg et al

in Frontiers in Human Neuroscience (2012, September)

Detailed reference viewed: 19 (2 ULg)
Full Text
Peer Reviewed
See detailA novel CACNA1A mutation results in episodic ataxia with migrainous features without headache
MAGIS, Delphine ULg; Boon, Elles; Coppola, Gianluca et al

in Cephalalgia : An International Journal of Headache (2012)

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailAdvances and challenges in neurostimulation for headaches
MAGIS, Delphine ULg; Schoenen, Jean ULg

in Lancet Neurology (2012), 11(8), 708-719

Detailed reference viewed: 20 (1 ULg)
Full Text
Peer Reviewed
See detailNeurostimulation therapies for primary headache disorders: present and future
MAGIS, Delphine ULg; JENSEN, Rigmor; Schoenen, Jean ULg

in Current Opinion in Neurology (2012), 25(3), 269-276

Purpose of review Most pharmacological treatments of primary headache disorders are partially effective and have cumbersome side effects. Therapies with better efficacy and tolerance are needed ... [more ▼]

Purpose of review Most pharmacological treatments of primary headache disorders are partially effective and have cumbersome side effects. Therapies with better efficacy and tolerance are needed. Neurostimulation techniques may have this potential. This is an attempt to summarize the latest clinical trial results published in the field. Recent findings Hypothalamic deep brain stimulation is effective in drug-resistant chronic cluster headache (drCCH) but not riskless. Recent anatomical MRI studies indicate that the effective stimulation sites are rather widespread. Occipital nerve stimulation (ONS) seems to be effective in up to 76% of drCCH patients and its benefit long-lasting. A minority of patients are able to abandon preventive drugs. Its mechanism of action appears nonspecific. In chronic migraine, randomized controlled trials of ONS showed recently encouraging results, but long-term studies are missing. An ongoing sham-controlled trial suggests sphenopalatine ganglion neurostimulation (SPGS) efficacy in drCCH acute treatment, but possibly also in preventive therapy. Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) modulate cortical excitability and connectivity. TMS could prevent headache when applied over the occipital cortex during the migraine aura. Repetitive TMS and tDCS have provided mixed results in a few small studies and warrant further trials. Summary Neurostimulation therapies inaugurate a new era in headache management and offer a promising alternative to medications. Future studies are necessary to provide evidence-based efficacy data, knowledge on their mode of action and information about their pharmaco-economic advantages. [less ▲]

Detailed reference viewed: 33 (0 ULg)